Adenocarcinoma of the lung: Current concepts in radiologic diagnosis and management

Current Opinion in Pulmonary Medicine

Volumn 13, Issue 4, 2007, Pages 261-266

  Shiau, Maria C ^a   Bonavita, John ^a   Naidich, David P ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenocarcinoma; Atypical adenomatous hyperplasia; Bronchioloalveolar cell carcinoma; Groundglass opacity; Lung cancer; Pulmonary nodule

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR;

CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER INVASION; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; FOLLOW UP; HUMAN; LOBECTOMY; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG NODULE; LUNG NON SMALL CELL CANCER; MORPHOLOGY; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIODIAGNOSIS; REVIEW; THORAX SURGERY; TIME; TRANSBRONCHIAL BIOPSY; TREATMENT INDICATION; TUMOR VOLUME;

ADENOCARCINOMA; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34249825795     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e3281c9b107     Document Type: Review

References (46)

1. Christiani DC, Pao W, DeMartini JC, et al. BAC Consensus Conference, November 4-6 2004: Epidemiology, pathogenesis, and preclinical models. J Thorac Oncol 2006; 1:S2-S7. This is the most recent consensus statement regarding bronchoalveolar cell carcinoma.
2. Travis WD, Colby TV, Corrin B, et al. Histologic typing of lung and pleural tumors. In: WHO World Health Organization Pathology Panel, editor. WHO International Histological Classification of Tumors. New York: Springer Verlag; 1999. pp. 46-55.
3. Travis WD, Garg K, Franklin WA, et al. Bronchioloalveolar carcinoma and lung adenocarcinoma: The clinical importance and research relevance of the 2004 World Health Organization pathologic criteria. J Thorac Oncol 2006; 1:S13-S19. This is the most recent definitive statement regarding the pathology of the spectrum of adenocarcinoma of the lung.
4. Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung: histologic characteristics and prognosis. Cancer 1995; 75:2844-2852.
5. Noguchi M, Shimosato Y. The development and progression of adenocarcinoma of the lung. Cancer Treat Res 1995; 72:131-142.
6. Aoki T, Nakaata H, Watanabe HEA. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling times. AJR Am J Roentgenol 2000; 174:763-768.
7. Ohtsuka T, Watanabe K, Kaji M, et al. A clinicopathologic study of resected pulmonary nodules with focal pure ground-glass opacity. Eur J Cardiothorac Surg 2006; 30:160-163. This is a recent excellent assessment of pathology of pure ground-glass lesions.
8. Ohta Y, Shimizu Y, Kobayashi T, et al. Pathologic and biological assessment of lung tumors showing ground-glass opacity. Ann Thor Surg 2006; 81:1194-1198. This is a recent excellent assessment of pathology of pure ground-glass lesions.
9. Gaeta M, Caruso R, Barone M, et al. Ground-glass attenuation in nodular bronchioloalveolar carcinoma: CT patterns and prognostic value. J Comput Assist Tomogr 1998; 22:215-219.
10. Gandara DR, Aberle D, Lau D, et al. Radiographic imaging of bronchioloalveolar carcinoma: Screening, patterns of presentation and response assessment. J Thorac Oncol 2006; 1:S20-S26. This is an up to date assessment of significance of subsolid nodules identified at screening.
11. Suzuki K, Kusumoto M, Watanabe S, et al. Radiologic classification of small adenocarcinomaof the lung: radiologic pathologic correlation and its prognostic impact. Ann Thor Surg 2006; 81:413-420.
12. Barsky SH, Cameron R, Osann KE, et al. Rising incidence of bronchioloalveolar lung cancer and its unique clinicopathologic features. Cancer 1994; 73:1163-1170.
13. Beasley MB, Brambilla E, Travis WD, et al. The 2004 World Health Organization classification of lung tumors. Semin Roentgenol 2005; 40:90-97.
14. Ebright MI, Zakowski MF, Corrin B, et al. Clinical pattern and pathologic stage but not histologic features predict outcome for bronchioloaloveolar carcinoma. Ann Thor Surg 2002; 74:1640-1646.
15. Miller VA, Kris MG, Shah N, et al. Bronchioloalveolar subtype and smoking history predict sensitivity to gefitinib in advanced nonsmall cell lung cancer. J Clin Oncol 2004; 22:1103-1109.
16. Ishikawa H, Koizumi N, Morita T, et al. Ultrasmall pulmonary opacities on multidetector-row high-resolution computed tomography: a prospective radiologic-pathologic examination. J Comput Assist Tomogr 2005; 29:621-625.
17. Kodama K, Higashiyama M, Yokouchi H, et al. Natural history of pure groundglass opacity after long-term follow-up of more than 2 years. Ann Thorac Surg 2002; 73:386-392.
18. Nakata M, Saeki H, Takata I, et al. Focal ground-glass opacity detected by low-dose helical CT. Chest 2002; 121:1464-1467.
19. Mirtcheva RM, Vasquez M, Yankelevitz DF, et al. Bronchioloalveolar carcinoma and adenocarcinoma with bronchioloalveolar features presenting as ground-glass opacities on CT. Clin Imaging 2002; 26:95-100.
20. Tsushima T, Suzuki K, Watanabe S, et al. Multiple lung adenocarcinomas showing ground-glass opacities on thoracic computed tomography. Ann Thor Surg 2006; 82:1508-1510. This important paper evaluates the significance of multiple subsolid nodules.
21. Higashiyama M, Kodama K, Yokouchi H, et al. Prognostic value of bronchioloalveolar carcinoma component of small lung adenocarcinoma. Ann Thorac Surg 1999; 68:2069-2073.
22. Asamura H, Suzuki K, Watanabe S, et al. A clinicopathological study of resected subcentimeter lung cancers: A favorable prognosis for ground glass opacity lesions. Ann Thorac Surg 2003; 76:1016-1022.
23. Takashima S, Maruyama Y, Hasegawa M, et al. High-resolution CT features: prognostic significance in peripheral lung adenocarcinoma with bronchioloalveolar carcinoma components. Respiration 2003; 70:36-42.
24. Travis WD, Garg K, Franklin WA, et al. Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol 2005; 23:3279-3287.
25. Sakao Y, Miyamoto H, Sakuraba M. Prognostic significance of a histologic subtype in small adenocarcinoma of the lung: the impact of nonbronchioloalveolar carcinoma components. Ann Thor Surg 2007; 83:209-215. This research documents the prognostic significance of the proportion of ground-glass attenuation.
26. Lin DM, Ma Y, Zheng S, et al. Prognostic value of bronchioloalveolar carcinoma component in lung adenocarcinoma. Histol Histopathol 2006; 21:627-632. This research documents the prognostic significance of the proportion of ground-glass attenuation.
27. Suzuki K, Koike T, Shibusa T, et al. Evaluation of radiologic diagnosis in peripheral clinical 1A lung cancers: a prospective study for radiological diagnosis of peripheral early lung cancer (JCOG 0201). J Clin Oncol 2006; 24:419S.
28. Henschke CI, Yankelevitz DF, Mirtcheva RM, et al. CT screening for lung cancer: frequency and significance of part-solid and nonsolid nodules. AJR Am J Roentgenol 2002; 178:1053-1057.
29. Yoon HE, Fukuhara K, Michiurs T, et al. Pulmonary nodules 10mm or less in diameter with ground-glass opacity component detected by high-resolution computed tomography have a high possibility of malignancy. Jpn J Thorac Cardiovasc Surg 2005; 53:22-28.
30. Flieder D, Vasquez M, Carter D, et al. Pathologic findings of lung tumors diagnosed on baseline CT screening. Am J Surg Pathol 2006; 30:606-613.
31. Asamura H, Goya T, Koshiishi Y, et al. How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese lung cancer registry populations. J Thorac Cardiovas Surg 2006; 132:316-319.
32. Ost D, Fein AM, Feinsilver SH. The solitary pulmonary nodule. N Engl J Med 2003; 348:2535-2542.
33. Libby DM, Smith JP, Altorki NK, et al. Managing the small pulmonary nodule discovered by CT. Chest 2004; 125:1522-1529.
34. Henschke CI, Yankelevitz DF, Naidich DP, et al. CT screening for lung cancer: suspicousness of nodules according to size on baseline scans. Radiology 2004; 231:164-168.
35. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology 2005; 235:259-265.
36. MacMahon H, Austin JHM, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005; 237:395-400.
37. Hasegawa M, Sone S, Takashima SEA. Growth rate of small lung cancers detected on mass CT screening. Br J Radiol 2000; 73:1252-1259.
38. Yankelevitz D, Kostis WJ, Henschke C, et al. Overdiagnosis in chest radio-graphic screening for lung carcinoma: frequency. Cancer 2003; 97:1271-1275.
39. Yankelevitz DF, Henschke C. Does 2-year stability imply that pulmonary nodules are benign? AJR Am J Roentgenol 1997; 168:325-328.
40. Revel MP, Bissery A, Bienvenu M, et al. Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable? Radiology 2004; 231:453-458.
41. Jennings SG, WinerMuram HT, Tarver RD, et al. Lung tumor growth: assessment with CT - comparison of diameter and cross-sectional area with volume measurements. Radiology 2004; 231:866-871.
42. Tran LN, Brown MS, Goldin JG, et al. Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography. Acad Radiol 2004; 11:1355-1360.
43. Yankelevitz DF, Reeves AP, Kostis WJ. Small pulmonary nodules; volumetrically determined growth rates based on CT evaluation. Radiology 2000; 217:251-256.
44. Takashima S, Maruyama Y, Hasegawa M, et al. CT findings and progression of small peripheral lung neoplasms having a replacement growth pattern. AJR Am J Roentgenol 2003; 180:817-826.
45. Rusch VW, Tsuchiya R, Tsuboi M, et al. Surgery for bronchioloalveolar carcinoma and "very early" adenocarcinoma: an evolving standard of care? J Thorac Oncol 2006; 1:S27-S31.
46. Yap CS, Schiepers C, Fishbein MC, et al. FDG-PET imaging in lung cancer: how sensitive is it for bronchioloalveolar carcinoma? Eur J Nucl Med Mol Imaging 2002; 29:1166-1173.